Clinical Trials Browser

Pancreatic Neoplasms × talimogene laherparepvec × Clear all

NCT03086642 2024-11-22

Study of Talimogene Laherparepvec (T-VEC) in Pancreatic Cancer

Phase 1 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT00402025 2016-04-15

Talimogene Laherparepvec in Patients With Unresectable Pancreatic Cancer

Phase 1 Completed

17 enrolled 14 charts

Gastrointestinal

Adenocarcinoma, Neoplasm Metastasis, Pancreatic Neoplasms